{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:24Z","timestamp":1761896124502},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aminoacyl-tRNA synthetases (AARSs) catalyze an early step in protein synthesis, but also regulate diverse physiological processes in animal cells. These include angiogenesis and human threonyl-tRNA synthetase (TARS) represents a potent pro-angiogenic AARS. Angiogenesis stimulation can be blocked by the macrolide antibiotic borrelidin (BN), which exhibits a broad spectrum toxicity that has discouraged deeper investigation. Recently, a less toxic variant (BC194) was identified that potently inhibits angiogenesis. Employing biochemical, cell biological and biophysical approaches, we demonstrate that the toxicity of BN and its derivatives is linked to its competition with the threonine substrate at the molecular level, which stimulates amino acid starvation and apoptosis. By separating toxicity from the inhibition of angiogenesis, a direct role for TARS in vascular development in the zebrafish could be demonstrated. Bioengineered natural products are thus useful tools in unmasking the cryptic functions of conventional enzymes in the regulation of complex processes in higher metazoans.<\/jats:p>","DOI":"10.1038\/srep13160","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T11:41:01Z","timestamp":1439552461000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor"],"prefix":"10.1038","volume":"5","author":[{"given":"Adam C.","family":"Mirando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara F.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda C.","family":"Baldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan K.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia M.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrie","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Lounsbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Francklyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"BFsrep13160_CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.biochem.69.1.617","volume":"69","author":"M Ibba","year":"2000","unstructured":"Ibba, M. & Soll, D. Aminoacyl-tRNA synthesis. Ann. Rev. Biochem. 69, 617\u2013650 (2000).","journal-title":"Ann. Rev. Biochem."},{"key":"BFsrep13160_CR2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/emmm.201100626","volume":"5","author":"P Yao","year":"2013","unstructured":"Yao, P. & Fox, P. L. Aminoacyl-tRNA synthetases in medicine and disease. EMBO Mol Med 5, 332\u2013343 (2013).","journal-title":"EMBO Mol Med"},{"key":"BFsrep13160_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1126\/science.284.5411.147","volume":"284","author":"K Wakasugi","year":"1999","unstructured":"Wakasugi, K. & Schimmel, P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase [see comments]. Science 284, 147\u2013151 (1999).","journal-title":"Science"},{"key":"BFsrep13160_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2004.09.030","volume":"119","author":"P Sampath","year":"2004","unstructured":"Sampath, P. et al. Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell 119, 195\u2013208 (2004).","journal-title":"Cell"},{"key":"BFsrep13160_CR5","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1073\/pnas.0500226102","volume":"102","author":"SG Park","year":"2005","unstructured":"Park, S. G. et al. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Natl Acad Sci USA 102, 6356\u20136361 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep13160_CR6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1096\/fj.07-9973com","volume":"22","author":"Y Greenberg","year":"2008","unstructured":"Greenberg, Y. et al. The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells. FASEB J 22, 1597\u20131605 (2008).","journal-title":"FASEB J"},{"key":"BFsrep13160_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nchembio.1158","volume":"9","author":"M Guo","year":"2013","unstructured":"Guo, M. & Schimmel, P. Essential nontranslational functions of tRNA synthetases. Nat Chem Biol 9, 145\u2013153 (2013).","journal-title":"Nat Chem Biol"},{"key":"BFsrep13160_CR8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/375039","volume":"72","author":"A Antonellis","year":"2003","unstructured":"Antonellis, A. et al. Glycyl tRNA Synthetase Mutations in Charcot-Marie-Tooth Disease Type 2D and Distal Spinal Muscular Atrophy Type V. Am J Hum Genet 72, 1293\u20131299 (2003).","journal-title":"Am J Hum Genet"},{"key":"BFsrep13160_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng1727","volume":"38","author":"A Jordanova","year":"2006","unstructured":"Jordanova, A. et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38, 197\u2013202 (2006).","journal-title":"Nat Genet"},{"key":"BFsrep13160_CR10","doi-asserted-by":"crossref","first-page":"e28936","DOI":"10.1371\/journal.pone.0028936","volume":"7","author":"EG Puffenberger","year":"2012","unstructured":"Puffenberger, E. G. et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One 7, e28936 (2012).","journal-title":"PLoS One"},{"key":"BFsrep13160_CR11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ng2013","volume":"39","author":"GC Scheper","year":"2007","unstructured":"Scheper, G. C. et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nature Genetics 39, 534\u2013539 (2007).","journal-title":"Nature Genetics"},{"key":"BFsrep13160_CR12","doi-asserted-by":"crossref","unstructured":"Kodera, H. et al. Mutations in the glutaminyl-tRNA synthetase gene cause early-onset epileptic encephalopathy. J Hum Genet, (in press) (2014).","DOI":"10.1038\/jhg.2014.103"},{"key":"BFsrep13160_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0014-5793(96)00073-7","volume":"381","author":"A Vartanian","year":"1996","unstructured":"Vartanian, A., Narovlyansky, A., Amchenkova, A., Turpaev, K. & Kisselev, L. Interferons induce accumulation of diadenosine triphosphate (Ap3A) in human cultured cells. FEBS Lett 381, 32\u201334 (1996).","journal-title":"FEBS Lett"},{"key":"BFsrep13160_CR14","doi-asserted-by":"crossref","first-page":"20124","DOI":"10.1074\/jbc.C200126200","volume":"277","author":"K Wakasugi","year":"2002","unstructured":"Wakasugi, K., Slike, B. M., Hood, J., Ewalt, K. L., Cheresh, D. A. & Schimmel, P. Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase. J Biol Chem 277, 20124\u201320126 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep13160_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1073\/pnas.012602099","volume":"99","author":"K Wakasugi","year":"2002","unstructured":"Wakasugi, K. et al. A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci USA 99, 173\u2013177 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep13160_CR16","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1074\/jbc.C400431200","volume":"280","author":"E Tzima","year":"2005","unstructured":"Tzima, E., Reader, J. S., Irani-Tehrani, M., Ewalt, K. L., Schwartz, M. A. & Schimmel, P. VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function. J Biol Chem 280, 2405\u20132408 (2005).","journal-title":"J Biol Chem"},{"key":"BFsrep13160_CR17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.108.191189","volume":"104","author":"H Fukui","year":"2009","unstructured":"Fukui, H., Hanaoka, R. & Kawahara, A. Noncanonical activity of seryl-tRNA synthetase is involved in vascular development. Circ Res 104, 1253\u20131259 (2009).","journal-title":"Circ Res"},{"key":"BFsrep13160_CR18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.108.191718","volume":"104","author":"W Herzog","year":"2009","unstructured":"Herzog, W., Muller, K., Huisken, J. & Stainier, D. Y. Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development. Circ Res 104, 1260\u20131266 (2009).","journal-title":"Circ Res"},{"key":"BFsrep13160_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/srep01317","volume":"3","author":"TF Williams","year":"2013","unstructured":"Williams, T. F., Mirando, A. C., Wilkinson, B., Francklyn, C. S. & Lounsbury, K. M. Secreted Threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis. Scientific Reports 3, 1317, 10.1038\/srep01317 (2013).","journal-title":"Scientific Reports"},{"key":"BFsrep13160_CR20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/1471-2407-14-620","volume":"14","author":"TL Wellman","year":"2014","unstructured":"Wellman, T. L. et al. Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. BMC Cancer 14, 620 (2014).","journal-title":"BMC Cancer"},{"key":"BFsrep13160_CR21","first-page":"476","volume":"22","author":"J Berger","year":"1949","unstructured":"Berger, J., Jampolsky, L. M. & Goldberg, M. W. Borrelidin, a new antibiotic with antiborrelia activity and penicillin enhancement properties. Arch Biochem 22, 476\u2013478 (1949).","journal-title":"Arch Biochem"},{"key":"BFsrep13160_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/206269a0","volume":"206","author":"K Anderton","year":"1965","unstructured":"Anderton, K. & Rickards, R. W. Some structural features of borrelidin, an anti-viral antibiotic. Nature 206, 269 (1965).","journal-title":"Nature"},{"issue":"2","key":"BFsrep13160_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpara.2011.11.008","volume":"42","author":"Katherine E. Jackson","year":"2012","unstructured":"Jackson, K. E. et al. Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum. Int J Parasitol 42, 177 186.","journal-title":"International Journal for Parasitology"},{"key":"BFsrep13160_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bph.12156","volume":"169","author":"IG Azcarate","year":"2013","unstructured":"Azcarate, I. G. et al. Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin. Br J Pharmacol 169, 645\u2013658 (2013).","journal-title":"Br J Pharmacol"},{"key":"BFsrep13160_CR25","first-page":"319","volume":"11","author":"Y Funahashi","year":"1999","unstructured":"Funahashi, Y. et al. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor. Oncology Research 11, 319\u2013329 (1999).","journal-title":"Oncology Research"},{"key":"BFsrep13160_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1432-1033.1973.tb02843.x","volume":"35","author":"W Paetz","year":"1973","unstructured":"Paetz, W. & Nass, G. Biochemical and immunological characterization of threonyl-tRNA synthetase of two borrelidin-resistant mutants of Escherichia coli K12. Eur J Biochem 35, 331\u2013337 (1973).","journal-title":"Eur J Biochem"},{"key":"BFsrep13160_CR27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00337933","volume":"147","author":"G Nass","year":"1976","unstructured":"Nass, G. & Poralla, K. Genetics of borrelidin resistant mutants of Saccharomyces cerivisiae and properties of their threonyl-tRNA-synthetase. Mol Gen Genet 147, 39\u201343 (1976).","journal-title":"Mol Gen Genet"},{"key":"BFsrep13160_CR28","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1073\/pnas.78.9.5367","volume":"78","author":"JS Gantt","year":"1981","unstructured":"Gantt, J. S., Bennett, C. A. & Arfin, S. M. Increased levels of threonyl-tRNA synthetase in a borrelidin-resistant Chinese hamster ovary cell line. Proc Natl Acad Sci USA 78, 5367\u20135370 (1981).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep13160_CR29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1074\/jbc.M411039200","volume":"280","author":"B Ruan","year":"2005","unstructured":"Ruan, B. et al. A unique hydrophobic cluster near the active site contributes to differences in borrelidin inhibition among threonyl-tRNA synthetases. J Biol Chem 280, 571\u2013577 (2005).","journal-title":"J Biol Chem"},{"key":"BFsrep13160_CR30","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1038\/ncomms7402","volume":"6","author":"P Fang","year":"2015","unstructured":"Fang, P. et al. Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase. Nat Commun 6, 6402 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep13160_CR31","first-page":"273","volume":"2","author":"J Woolard","year":"2011","unstructured":"Woolard, J. et al. Borrelidin modullates the alternative splicing of VEGF in favor of antiangiogenic isoforms Chemical Science 2, 273\u2013278 (2011).","journal-title":"Science"},{"key":"BFsrep13160_CR32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jat.2946","volume":"34(10)","author":"D Gafiuc","year":"2014","unstructured":"Gafiuc, D., Weiss, M., Mylonas, I. & Bruning, A. Borrelidin has limited anti-cancer effects in bcl-2 overexpressing breast cancer and leukemia cells and reveals toxicity in non-malignant breast epithelial cells. J Appl Toxicol 34(10), 1109\u20131113 (2014).","journal-title":"J Appl Toxicol"},{"key":"BFsrep13160_CR33","doi-asserted-by":"crossref","unstructured":"Moss, S. J. et al. Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues. Chem Commun (Camb), 2341\u20132343, 10.1039\/b602931k (2006).","DOI":"10.1039\/B602931K"},{"key":"BFsrep13160_CR34","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.bmcl.2006.08.073","volume":"16","author":"B Wilkinson","year":"2006","unstructured":"Wilkinson, B. et al. Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain. Bioorg Med Chem Lett 16, 5814\u20135817 (2006).","journal-title":"Bioorg Med Chem Lett"},{"key":"BFsrep13160_CR35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7164\/antibiotics.50.671","volume":"50","author":"T Wakabayashi","year":"1997","unstructured":"Wakabayashi, T. et al. Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model. J Antibiot (Tokyo) 50, 671\u2013676 (1997).","journal-title":"J Antibiot (Tokyo)"},{"key":"BFsrep13160_CR36","first-page":"87","volume":"11","author":"C Olano","year":"2004","unstructured":"Olano, C. et al. Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tu4055: cluster analysis and assignment of functions. 6. Chemistry & Biology 11, 87\u201397 (2004).","journal-title":"Chemistry & Biology"},{"key":"BFsrep13160_CR37","doi-asserted-by":"crossref","unstructured":"Fang, P. et al. Structural Basis for Full-Spectrum Inhibition of Translational Functions on a tRNA synthetase. Nature Communications. 6:6402, 10.1038\/ncomms7402 (2015).","DOI":"10.1038\/ncomms7402"},{"key":"BFsrep13160_CR38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/75856","volume":"7","author":"R Sankaranarayanan","year":"2000","unstructured":"Sankaranarayanan, R. et al. Zinc ion mediated amino acid discrimination by threonyl-tRNA synthetase. Nature Structural Biology 7, 461\u2013465 (2000).","journal-title":"Nature Structural Biology"},{"key":"BFsrep13160_CR39","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1089\/ars.2007.1764","volume":"9","author":"RC Wek","year":"2007","unstructured":"Wek, R. C. & Cavener, D. R. Translational control and the unfolded protein response. Antioxid Redox Signal 9, 2357\u20132371 (2007).","journal-title":"Antioxid Redox Signal"},{"key":"BFsrep13160_CR40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BST0340007","volume":"34","author":"RC Wek","year":"2006","unstructured":"Wek, R. C., Jiang, H. Y. & Anthony, T. G. Coping with stress: eIF2 kinases and translational control. Biochemical Society Transactions 34, 7\u201311 (2006).","journal-title":"Biochemical Society Transactions"},{"key":"BFsrep13160_CR41","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0960-894X(03)00406-2","volume":"13","author":"EL Eastwood","year":"2003","unstructured":"Eastwood, E. L. & Schaus, S. E. Borrelidin induces the transcription of amino acid biosynthetic enzymes via a GCN4-dependent pathway. Bioorganic & Medicinal Chemistry Letters 13, 2235\u20132237 (2003).","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"BFsrep13160_CR42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0092-8674(77)90209-4","volume":"12","author":"RF Brooks","year":"1977","unstructured":"Brooks, R. F. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12, 311\u2013317 (1977).","journal-title":"Cell"},{"key":"BFsrep13160_CR43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1126\/science.1172638","volume":"324","author":"MS Sundrud","year":"2009","unstructured":"Sundrud, M. S. et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science 324, 1334\u20131338 (2009).","journal-title":"Science"},{"key":"BFsrep13160_CR44","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1091\/mbc.e05-03-0268","volume":"16","author":"RB Hamanaka","year":"2005","unstructured":"Hamanaka, R. B., Bennett, B. S., Cullinan, S. B. & Diehl, J. A. PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Molecular Biology of the Cell 16, 5493\u20135501 (2005).","journal-title":"Molecular Biology of the Cell"},{"key":"BFsrep13160_CR45","doi-asserted-by":"crossref","first-page":"E5508","DOI":"10.1073\/pnas.1405994111","volume":"111","author":"EM Novoa","year":"2014","unstructured":"Novoa, E. M. et al. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo. Proc Natl Acad Sci USA 111, E5508\u2013E5517 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep13160_CR46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7164\/antibiotics.56.709","volume":"56","author":"T Kawamura","year":"2003","unstructured":"Kawamura, T. et al. Anti-angiogenesis effects of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells. Journal of Antibiotics 56, 709\u2013715 (2003).","journal-title":"Journal of Antibiotics"},{"key":"BFsrep13160_CR47","doi-asserted-by":"crossref","first-page":"17748","DOI":"10.1073\/pnas.0804247105","volume":"105","author":"A Minajigi","year":"2008","unstructured":"Minajigi, A. & Francklyn, C. S. RNA-assisted catalysis in a protein enzyme: The 2\u2019-hydroxyl of tRNA(Thr) A76 promotes aminoacylation by threonyl-tRNA synthetase. Proc. Natl. Acad. Sci. USA. 105, 17748\u201317753 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep13160_CR48","first-page":"2981","volume":"29","author":"R Harisi","year":"2009","unstructured":"Harisi, R. et al. Differential inhibition of single and cluster type tumor cell migration. Anticancer Res 29, 2981\u20132985 (2009).","journal-title":"Anticancer Res"},{"key":"BFsrep13160_CR49","doi-asserted-by":"crossref","unstructured":"McKenzie, A. J., Campbell, S. L. & Howe, A. K. Protein kinase A activity and anchoring are required for ovarian cancer cell migration and invasion. PLoS One 6, e26552.","DOI":"10.1371\/journal.pone.0026552"},{"key":"BFsrep13160_CR50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nature05577","volume":"445","author":"AF Siekmann","year":"2007","unstructured":"Siekmann, A. F. & Lawson, N. D. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445, 781\u2013784 (2007).","journal-title":"Nature"},{"key":"BFsrep13160_CR51","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bbrc.2006.01.020","volume":"341","author":"T Iso","year":"2006","unstructured":"Iso, T. et al. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem Biophys Res Commun 341, 708\u2013714 (2006).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep13160_CR52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0925-4773(00)00459-7","volume":"98","author":"C Leimeister","year":"2000","unstructured":"Leimeister, C., Schumacher, N., Steidl, C. & Gessler, M. Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. Mech Dev 98, 175\u2013178 (2000).","journal-title":"Mech Dev"},{"key":"BFsrep13160_CR53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrmicro2278","volume":"8","author":"CM Thomas","year":"2010","unstructured":"Thomas, C. M., Hothersall, J., Willis, C. L. & Simpson, T. J. Resistance to and synthesis of the antibiotic mupirocin. Nat Rev Microbiol 8, 281\u2013289 (2010).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep13160_CR54","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","volume":"316","author":"FL Rock","year":"2007","unstructured":"Rock, F. L. et al. An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site. Science 316, 1759\u20131761 (2007).","journal-title":"Science"},{"key":"BFsrep13160_CR55","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1021\/jm8000746","volume":"51","author":"P Van de Vijver","year":"2008","unstructured":"Van de Vijver, P. et al. Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. J Med Chem 51, 3020\u20133029 (2008).","journal-title":"J Med Chem"},{"key":"BFsrep13160_CR56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nchembio.1381","volume":"10","author":"DG Kim","year":"2014","unstructured":"Kim, D. G. et al. Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction. Nat Chem Biol 10, 29\u201334 (2014).","journal-title":"Nat Chem Biol"},{"key":"BFsrep13160_CR57","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cellsig.2014.03.009","volume":"26","author":"W B\u2019Chir","year":"2014","unstructured":"B\u2019Chir, W. et al. Dual role for CHOP in the crosstalk between autophagy and apoptosis to determine cell fate in response to amino acid deprivation. Cell Signal 26, 1385\u20131391 (2014).","journal-title":"Cell Signal"},{"key":"BFsrep13160_CR58","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10637-011-9700-y","volume":"30(4)","author":"D Habibi","year":"2012","unstructured":"Habibi, D. et al. Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia. Invest New Drugs 30(4), 1361\u20131370 (2012).","journal-title":"Invest New Drugs"},{"key":"BFsrep13160_CR59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-2836(03)00719-8","volume":"331","author":"A Torres-Larios","year":"2003","unstructured":"Torres-Larios, A., Sankaranarayanan, R., Rees, B., Dock-Bregeon, A. C. & Moras, D. Conformational movements and cooperativity upon amino acid, ATP and tRNA binding in threonyl-tRNA synthetase. Journal of Molecular Biology 331, 201\u2013211 (2003).","journal-title":"Journal of Molecular Biology"},{"key":"BFsrep13160_CR60","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1101\/gad.242002","volume":"16","author":"C Ruhrberg","year":"2002","unstructured":"Ruhrberg, C. et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16, 2684\u20132698 (2002).","journal-title":"Genes Dev"},{"key":"BFsrep13160_CR61","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm2183","volume":"8","author":"RH Adams","year":"2007","unstructured":"Adams, R. H. & Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8, 464\u2013478 (2007).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep13160_CR62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/ATVBAHA.107.158014","volume":"28","author":"D Vestweber","year":"2008","unstructured":"Vestweber, D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28, 223\u2013232 (2008).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep13160_CR63","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/mol.64.5.1029","volume":"64","author":"MT Lin","year":"2003","unstructured":"Lin, M. T., Yen, M. L., Lin, C. Y. & Kuo, M. L. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64, 1029\u20131036 (2003).","journal-title":"Mol Pharmacol"},{"key":"BFsrep13160_CR64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.devcel.2009.08.011","volume":"17","author":"B Strilic","year":"2009","unstructured":"Strilic, B. et al. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 17, 505\u2013515 (2009).","journal-title":"Dev Cell"},{"key":"BFsrep13160_CR65","doi-asserted-by":"crossref","first-page":"23725","DOI":"10.3390\/ijms151223725","volume":"15","author":"AC Mirando","year":"2014","unstructured":"Mirando, A. C., Francklyn, C. S. & Lounsbury, K. M. Regulation of Angiogenesis by Aminoacyl-tRNA Synthetases. Int J Mol Sci 15, 23725\u201323748 (2014).","journal-title":"Int J Mol Sci"},{"key":"BFsrep13160_CR66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.tibs.2009.03.004","volume":"34","author":"R Mukhopadhyay","year":"2009","unstructured":"Mukhopadhyay, R., Jia, J., Arif, A., Ray, P. S. & Fox, P. L. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem Sci 34, 324\u2013331 (2009).","journal-title":"Trends Biochem Sci"},{"key":"BFsrep13160_CR67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nsmb.1706","volume":"17","author":"Q Zhou","year":"2010","unstructured":"Zhou, Q. et al. Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality. Nat Struct Mol Biol 17, 57\u201361 (2010).","journal-title":"Nat Struct Mol Biol"},{"key":"BFsrep13160_CR68","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1096\/fj.03-0143fje","volume":"18","author":"TL Wellman","year":"2004","unstructured":"Wellman, T. L. et al. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries. Faseb J 18, 379\u2013381 (2004).","journal-title":"Faseb J"},{"key":"BFsrep13160_CR69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","volume":"170","author":"SA Ahmed","year":"1994","unstructured":"Ahmed, S. A., Gogal, Jr., R. M. & Walsh, J. E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 170, 211\u2013224 (1994).","journal-title":"J Immunol Methods"},{"key":"BFsrep13160_CR70","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nprot.2010.6","volume":"5","author":"I Arnaoutova","year":"2010","unstructured":"Arnaoutova, I. & Kleinman, H. K. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5, 628\u2013635 (2010).","journal-title":"Nat Protoc"},{"key":"BFsrep13160_CR71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nprot.2006.13","volume":"1","author":"D Ribatti","year":"2006","unstructured":"Ribatti, D., Nico, B., Vacca, A. & Presta, M. The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 1, 85\u201391 (2006).","journal-title":"Nat Protoc"},{"key":"BFsrep13160_CR72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in Enzymology 276, 307\u2013326 (1997).","journal-title":"Methods in Enzymology"},{"key":"BFsrep13160_CR73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr 66, 22\u201325 (2010).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFsrep13160_CR74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFsrep13160_CR75","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFsrep13160_CR76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish. Dev Dyn 203, 253\u2013310 (1995).","journal-title":"Dev Dyn"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep13160","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep13160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep13160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:41:06Z","timestamp":1672958466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep13160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,10,16]]}},"alternative-id":["BFsrep13160"],"URL":"https:\/\/doi.org\/10.1038\/srep13160","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]},"assertion":[{"value":"25 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yes, there is a potential competing financial interest. BW is a shareholder in Isomerase Therapeutics Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13160"}}